Schwarz P, Halberg P
Ugeskr Laeger. 1989 Apr 24;151(17):1033-5.
The literature about pregnancies in patients with systemic lupus erythematosus (SLE) was reviewed. Information about 1,164 pregnancies was compiled. Fifty-four per cent of the pregnancies were normal, 15 per cent of the babies were premature, and 29 per cent of the pregnancies resulted in fetal wastage. In a background population of 50,000 women the corresponding figures were 80, 4 and 16 per cent, respectively. The neonatal mortality of babies borne by women with SLE was 2 per cent. About one third of the patients had an exacerbation of their disease, mostly post-partum or during the last trimester of the pregnancy. The risk of a exacerbation for patients with active disease at the time of conception was double that of patients with inactive disease. Therapeutic abortions were followed by improvement as well as deterioration of the disease. Two per cent of the patients died during pregnancy or post-partum. Cardiolipin-antibody may be a marker of fetal wastage and Ro-antibody may be a marker of fetal heart block in babies borne by women with SLE. Pregnancy was previously considered inadvisable in all patients with SLE. During recent years, the attitude to this problem has been less rigid. However the patients should be fully informed about the risk of exacerbation, fetal wastage, and premature delivery and patients with active disease should be advised to postpone pregnancy until a remission has been achieved.
对系统性红斑狼疮(SLE)患者妊娠的相关文献进行了综述。收集了1164例妊娠的信息。54%的妊娠为正常妊娠,15%的婴儿早产,29%的妊娠导致胎儿丢失。在50000名女性的背景人群中,相应数字分别为80%、4%和16%。SLE女性所生婴儿的新生儿死亡率为2%。约三分之一的患者病情加重,大多在产后或妊娠晚期。妊娠时患有活动性疾病的患者病情加重的风险是无活动性疾病患者的两倍。治疗性流产后疾病有改善也有恶化。2%的患者在妊娠期间或产后死亡。抗心磷脂抗体可能是胎儿丢失的标志物,而Ro抗体可能是SLE女性所生婴儿发生胎儿心脏传导阻滞的标志物。以前认为所有SLE患者都不宜妊娠。近年来,对这个问题的态度没那么严格了。然而,应让患者充分了解病情加重、胎儿丢失和早产的风险,对于患有活动性疾病的患者,应建议其推迟妊娠直至病情缓解。